Search results
Results from the WOW.Com Content Network
Molecular Autism is a peer-reviewed open-access medical journal covering research on the cause, biology, and treatment of autism and related neurodevelopmental disorders. The journal was established in 2010 and is published by BioMed Central .
When used with the antiviral drug ribavirin, PEGylated interferon is effective in treatment of hepatitis C; at least 75% of people with hepatitis C genotypes 2 or 3 benefit from interferon treatment, although this is effective in less than 50% of people infected with genotype 1 (the more common form of hepatitis C virus in both the U.S. and ...
Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). [5] It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli. [6] Some research indicates that interferon injections may result in an 18–38% reduction in the rate of MS relapses. [7]
An interferon-stimulated gene (ISG) is a gene that can be expressed in response to stimulation by interferon. [ 1 ] [ 2 ] Interferons bind to receptors on the surface of a cell, initiating protein signaling pathways within the cell.
Interferon beta-1b is available only in injectable forms, and can cause skin reactions at the injection site that may include cutaneous necrosis. Skin reactions vary greatly in their clinical presentation. [2] They usually appear within the first month of treatment albeit their frequence and importance diminish after six months of treatment. [2]
Interferon alfa or HuIFN-alpha-Le, trade name Multiferon, is a pharmaceutical drug composed of natural interferon alpha (IFN-α), obtained from the leukocyte fraction of human blood following induction with Sendai virus. Interferon alfa contains several naturally occurring IFN-α subtypes and is purified by affinity chromatography.
Interferon alfa-2b is an antiviral or antineoplastic drug. It is a recombinant form of the protein Interferon alpha-2 that was originally sequenced and produced recombinantly in E. coli [ 1 ] in the laboratory of Charles Weissmann at the University of Zurich , in 1980.
Type III interferon receptors are expressed more specifically on epithelial cells and some immune cells such as neutrophils, and depending on the species, B cells and dendritic cells as well. [ 13 ] [ 14 ] [ 15 ] Therefore, their antiviral effects are most prominent in barriers, in gastrointestinal, respiratory and reproductive tracts.